Skip to content

More Compelling Evidence to Support Hip Resurfacing Arthroplasty

More Compelling Evidence to Support Hip Resurfacing Arthroplasty

More compelling evidence to support hip resurfacing arthroplasty. Published September 9, 2020, the paper discusses a study delivered by twenty seven hip resurfacing professionals from thirteen countries who collaborated to review a cohort of 11,382 hip resurfacing arthroplasties.

The focus was on a varied group of patients both male and female, ⩽50 years of age and aimed to analyse arthroplasty outcomes with a mean follow-up of 7.6 years. In total, 18 different metal-on-metal (MoM) hip resurfacing designs were included in the study.

​In men, implant survivorship was excellent: 99% at 10 years and 92.5% at 21 years.

In females, implant survivorship was 90% at 10 years and 81.3% at 22 years.

Implant survivorship of 11,063 cases was 95% at 10 years and 90% at 22 years

The authors note Higher demands for activity and functionality in younger patients make HRA a potential alternative to Total Hip Arthroplasty (THA).

Follow this link to read more: Hip resurfacing arthroplasty in young patients: international high-volume centres’ report on the outcome of 11,382 metal-on-metal hip resurfacing arthroplasties in patients ⩽50 years at surgery